In glucose-resistant overweight to obese patients, ER reduced insulin resistance and insulin-like growth factor 1 (IGF1) levels, [53] but this effect seems only transient [54] and limited to the weight-loss phase—except if accompanied by a reduction in protein intake [55]. Here, IGF1 is linked to Insulin resistance.